Skip to main content
OpenTrials
Withdrawn

NCT Number: NCT07741097

Prediction Model of Spontaneous Closure of Congenital Perimembranous Ventricular Septal Defects

The objective of this study is to establish a more comprehensive model for evaluating the condition of children with ventricular septal defect and predicting the probability and time of their spontaneous Closure.

Why the study stopped: Repeated application of the same project
Withdrawn

Looking for future studies?

Notify Me

Key information

Age range

Up to 14 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

About this study

This is an observational study with sufficient and complete preliminary research and pre-experimental foundations. This study used the "National Congenital Heart Disease Collaboration Network" platform to retrospectively collect electronic medical record of children with Perimembranous Ventricular Septal Defect(PMVSD)that met the criteria of this study. The minimum sample size is estimated to be 4,500. According to the observation of the natural course of PMVSD in children, they were divided into PMVSD spontaneously closed group and unclosed group. The objective of this study is to establish a data model, which can predict the spontaneous closure probability of congenital perimembranous ventricular septal defect and provide reliable basis for clinical diagnosis and therapy. Through the experience screening of clinical experts and big clinical data mining of large samples, PMVSD spontaneous closure related variables were extracted and were used to establish a more accurate and objective prediction for the natural course of PMVSD.This could provide reliable information for the clinical surgery timing and indications urgery thus is of important social significance and economic value.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The initial diagnosis age is from birth to 14 years old
  • Ultrasonography confirmed the presence of simple PMVSD or other simple congenital heart diseases without other complicated heart malformations (such as pulmonary venous drainage, conus trunk malformation, interruption of aortic arch, primary pulmonary hypertension, etc.)
  • No major disease at first diagnosis (life-threatening organic disease not caused by congenital heart disease)
  • The patient or guardian voluntarily signs the informed consent form

Exclusion criteria

  • The initial diagnosis age>14 years old.
  • With complicated congenital heart disease (such as pulmonary venous ectopic drainage, conus trunk malformation, interruption of aortic arch, primary pulmonary hypertension, etc.)
  • Serious diseases of other organs
  • Unable to cooperate with the doctor to complete regular outpatient follow-up or give up treatment

Treatment and study plan

Primary outcomes

  1. Proportion of participants with spontaneous closure of perimembranous ventricular septal defect confirmed by echocardiography

    Time frame: From baseline to December 2022

    Spontaneous closure is defined as the absence of a ventricular septal defect shunt on color Doppler echocardiography, without prior surgical or transcatheter closure intervention.

Sponsors and collaborators

Lead sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Other

Registry information

Official study title

Study on the Predicting Model for Spontaneous Closure of Perimembranous Ventricular Septal Defects in Children- An Observational Research Based on the Real World

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Aug 3, 2026
Registry last updated
Aug 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.